| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $7.54 | $6.77 | $6.79 | $5.94 | $6.30 | $1.16 | $1.01 | $0.85 |
| EPS (Diluted) | $7.49 | $6.71 | $6.73 | $5.87 | $6.20 | $1.14 | $0.99 | $0.84 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.6B | $9.0B | $8.5B | $7.9B | $6.1B | $5.7B | $4.9B | $4.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.1B |
| Total Liabilities | $8.5B | $8.0B | $7.7B | $7.2B | $5.4B | $5.1B | $4.4B | $4.5B |
| Current Liabilities | — | — | — | — | — | — | $0.0B | — |
| Stockholders' Equity | $1.1B | $1.0B | $0.9B | $0.8B | $0.7B | $0.6B | $0.5B | $0.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.9B | $-0.8B | $-0.7B | $-0.6B | $-0.4B | $-0.7B | $-0.3B | $-0.3B |
| Capital Expenditures | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.4B | $0.4B | $0.4B | $0.5B | $0.3B | $0.6B | $0.2B | $0.3B |